Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tina Hu-Seliger"'
Autor:
Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, Daniel H. Hovelson, Melissa J. Shreve, Laura E. Lamb, Marc R. Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E. Claire Dees, Adedayo A. Onitilo, Michael Thompson, Gary L. Buchschacher, Alan M. Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C. Hwang, J. Marie Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M. Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D. Bryan Johnson, Daniel R. Rhodes
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-14 (2023)
Tomlins et al. develop an Immunotherapy Response Score (IRS) to predict clinical benefit from checkpoint inhibition across solid tumors. IRS integrates TMB and gene expression, is evaluable from FFPE material, and is predictive for real-world progres
Externí odkaz:
https://doaj.org/article/4592ab4c5780454fabd8956daa3f8f79
Autor:
Ryan W. Dellinger, Holly E. Holmes, Tina Hu‐Seliger, Rodney W. Butt, Stephen A. Harrison, Dariush Mozaffarian, Oliver Chen, Leonard Guarente
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES.
The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.A 6-month prospective, randomized, double-blind, place
Autor:
Nickolay Khazanov, Melissa Shreve, Laura Lamb, Daniel Hovelson, Marc Matrana, Mark Burkard, Eddy Yang, William Edenfield, Claire Dees, Adedayo Onitilo, Michael Thompson, Gary Buchschacher, Alan Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon Hwang, J. Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer Slim, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Jennifer Hipp, Travis Reeder, Hana Vakil, Bryan Johnson, Daniel Rhodes, Scott Tomlins
Pembrolizumab is approved in many advanced solid tumor types, however predictive biomarkers and the proportion of pembrolizumab-benefiting patients vary. Biomarkers beyond PD-L1 immunohistochemistry, microsatellite instability (MSI) status, and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d44f832c2a2425bf32a36e8fa251391
https://doi.org/10.21203/rs.3.rs-1225960/v1
https://doi.org/10.21203/rs.3.rs-1225960/v1
Publikováno v:
Innovation in Aging
Epigenetic clocks are widely used aging biomarkers, but they are calculated from methylation data for individual CpGs that can be surprisingly unreliable. We report that technical noise causes six major epigenetic clocks to deviate by 3 to 9 years be
Autor:
Keri Kalmbach, Piraye Yurttas Beim, Tina Hu Seliger, Caterina Clementi, R. Mark Adams, David-Emlyn Parfitt
Publikováno v:
Fertility and Sterility. 107:e13